These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 134183)

  • 21. [Transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder in adult patients: our first clinical experiences].
    Kaya MG; Ozdoğru I; Baykan A; Doğan A; Inanç T; Doğdu O; Uzüm K; Narin N; Topsakal R; Ergin A; Oğuzhan A; Eryol NK
    Turk Kardiyol Dern Ars; 2008 Jul; 36(5):287-93. PubMed ID: 18984979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Non-surgical closure of patent ductus arteriosus: acute and long-term results].
    Chatterjee T; Windecker S; Pfammatter JP; Seiler C; Meier B
    Schweiz Med Wochenschr; 2000 May; 130(18):664-70. PubMed ID: 10846759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial and ventricular septal defects can safely be closed by percutaneous intervention.
    Hein R; Büscheck F; Fischer E; Leetz M; Bayard MT; Ostermayer S; Reschke M; Lang K; Römer A; Wilson N; Sievert H
    J Interv Cardiol; 2005 Dec; 18(6):515-22. PubMed ID: 16336434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcatheter closure of secundum atrial septal defects with the Amplatzer occluder in adult patients.
    Carcagnì A; Presbitero P
    Ital Heart J; 2002 Mar; 3(3):182-7. PubMed ID: 11974662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Operative findings in failed button device closure of ASD.
    Gutti RS; Dronamraju D; Saha A
    Ann Thorac Surg; 1995 Mar; 59(3):793-4. PubMed ID: 7887749
    [No Abstract]   [Full Text] [Related]  

  • 26. Controversies in the definition and management of insignificant left-to-right shunts.
    Cantinotti M; Assanta N; Murzi B; Lopez L
    Heart; 2014 Feb; 100(3):200-5. PubMed ID: 23886608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lyophilized glutaraldehyde-preserved bovine pericardium for experimental atrial septal defect closure.
    Santibáñez-Salgado JA; Olmos-Zúñiga JR; Pérez-López M; Aboitiz-Rivera C; Gaxiola-Gaxiola M; Jasso-Victoria R; Sotres-Vega A; Baltazares-Lipp M; Pérez-Covarrubias D; Villalba-Caloca J
    Eur Cell Mater; 2010 Apr; 19():158-65. PubMed ID: 20408127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The experimental production of a persistent ductus arteriosus for testing catheter closure devices.
    Warnecke I; Bücherl ES
    Ann Thorac Surg; 1985 May; 39(5):441-4. PubMed ID: 3994444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonoperative closure of atrial septal defects.
    King TD; Mills NL
    Surgery; 1974 Mar; 75(3):383-8. PubMed ID: 4811334
    [No Abstract]   [Full Text] [Related]  

  • 30. Mind the gap: closure of right to left shunts for rare indications.
    Ten Cate TJF; van Dijk APJ
    Neth Heart J; 2018 Nov; 26(11):533-534. PubMed ID: 30284686
    [No Abstract]   [Full Text] [Related]  

  • 31. Recognition of PDA's Outstanding Reviewers.
    PDA J Pharm Sci Technol; 2023; 77(1):53. PubMed ID: 36746624
    [No Abstract]   [Full Text] [Related]  

  • 32. Recognition of PDA's Outstanding Reviewers.
    PDA J Pharm Sci Technol; 2024; 78(1):140. PubMed ID: 38378228
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on Transcatheter Device Closure of Congenital Septal Defects.
    Wood KP; Fleming GA; Chamberlain RC
    Curr Cardiol Rep; 2023 Sep; 25(9):1083-1093. PubMed ID: 37523002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case report: Early thrombosis in left atrial during transcatheter closure of ASD in a child with favorable outcome after use of GPIIb/IIIa receptor antagonist and heparin.
    Wang H; Zhu Z; Liu Z; Yuan Y; Xu X; Liu L; Wen J; Xia X; Zhang Y; He J
    Front Pediatr; 2023; 11():1138717. PubMed ID: 36994437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Transcatheter or Surgical Closure of Atrial Septal Defect using Interpretable Deep Keypoint Stadiometry.
    Wang J; Xie W; Cheng M; Wu Q; Wang F; Li P; Fan B; Zhang X; Wang B; Liu X
    Research (Wash D C); 2022; 2022():9790653. PubMed ID: 36340508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early and Mid-Term Follow-Up Results After Transcatheter Closure of Secundum Atrial Septal Defect.
    Kılınç B; Eroğlu AG; Saltık İL
    Turk Arch Pediatr; 2022 Nov; 57(6):661-667. PubMed ID: 36314959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limitations of Percutaneous Closure of a Complex Secundum Atrial Septal Defect.
    Binder MS; Binder IE; Foerst JR
    CASE (Phila); 2022 Jul; 6(5):233-236. PubMed ID: 35832827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Echocardiography in the Diagnosis and Interventional Management of Atrial Septal Defects.
    Rao PS
    Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease.
    Divekar AA; Arar YM; Clark S; Tandon A; Zellers TM; Veeram Reddy SR
    Children (Basel); 2022 Apr; 9(4):. PubMed ID: 35455541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and Efficacy of the Amplatzer Septal Occluder: A Systematic Review and Meta-Analysis.
    Heaton JN; Okoh AK; Suh S; Ozturk E; Salemi A; Waxman S; Tayal R
    Cardiovasc Revasc Med; 2022 Apr; 37():52-60. PubMed ID: 34183276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.